Real‐world experience of rIX‐FP prophylaxis at dosing intervals of up to 14 days in a pediatric patient with hemophilia B during the COVID‐19 pandemic
Key Clinical Message Switching to rIX‐FP prophylaxis at dosing intervals of up to 14 days in a hemophilia B pediatric patient decreased treatment burden by reducing the number of administrations and hospital visits, without affecting efficacy or treatment adherence. This is particularly important in...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley
2023-12-01
|
| Series: | Clinical Case Reports |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1002/ccr3.8180 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|